By: 
Totie Mesia
Date: 
Wednesday, September 17th, 2008
More than thirty (30) drugs which include acyclovir, cirprofloxacin and simvastatin, manufactured in two Ranbaxy Laboratories (Dewas and Poenta Sahib plants) in India will not be permitted into the US. Without asking for recall of drugs already on the shelf, the Food Drug Administration (FDA,) the decision is based on the lack of compliance to safety and manufacturing standards by the Indian drug company.

The Food Drug Administration says no report of harm has been so far reported.

List of Drugs with Stop Order

User login